ATORVASTATIN Side Effects

6975830-2 | Cardiogenic Shock, Overdose, Renal Failure
on Aug 27, 2010 Male patient from NETHERLANDS , 75 years of age, was treated with Atorvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiogenic shock, overdose, renal failure. Atorvastatin dosage: 1200 Mg, Unk. During the same period patient was treated with DIGOXIN (7125 Mg, Unk) (View Digoxin Review and Digoxin Label ), SOTALOL (7200 Mg, Unk) (View Sotalol Review and Sotalol Label ), ISOSORBIDE (6000 Mg, Unk) (View Isosorbide Review and Isosorbide Label ), ACENOCOUMAROL (98 Mg, Unk) (View Acenocoumarol Review and Acenocoumarol Label ), PERINDOPRIL (200 Mg, Unk) (View Perindopril Review and Perindopril Label ), FUROSEMIDE (800 Mg, Unk) (View Furosemide Review and Furosemide Label ), AMLODIPINE (300 Mg, Unk) (View Amlodipine Review and Amlodipine Label ).

6972385-3 | Mononeuropathy, Rhabdomyolysis
Patient was taking Atorvastatin (View Usage). Patient had the following side effects: mononeuropathy, rhabdomyolysis on Aug 26, 2010 from ITALY Additional patient health information: Male patient , 59 years of age, was diagnosed with lung infection, dyslipidaemia and. Atorvastatin dosage: 40 Mg, Unk. During the same period patient was treated with CLARITHROMYCIN (500 Mg, Unk) (View Clarithromycin Review and Clarithromycin Label ), PRAVASTATIN (40 Mg, Unk) (View Pravastatin Review and Pravastatin Label ), INSULIN LISPRO (View Insulin Lispro Review and Insulin Lispro Label ), INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ), RAMIPRIL (5 Mg, Unk) (View Ramipril Review and Ramipril Label ), AMLODIPINE (10 Mg, Unk) (View Amlodipine Review and Amlodipine Label ).

6964040-0 | Liver Function Test Abnormal, Pyrexia
Adverse event was reported on Sep 02, 2010 by a Male patient taking Atorvastatin (View Usage) (Dosage: 10 Mg Every Day Po) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 88 years of age, After Atorvastatin was administered, patient had the following side effects: liver function test abnormal, pyrexia. Patient was hospitalized.

6940133-9 | Impaired Healing, Tendon Rupture
on Aug 11, 2010 Male patient from UNITED KINGDOM , 70 years of age, weighting 187.4 lb, was diagnosed with arthritis (What is arthritis?), muscle spasms and was treated with Atorvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: impaired healing, tendon rupture. Atorvastatin dosage: 10 Mg, Unk. During the same period patient was treated with SIMVASTATIN (20 Mg, Unk) (View Simvastatin Review and Simvastatin Label ), DICLOFENAC (50 Mg, Unk) (View Diclofenac Review and Diclofenac Label ), QUININE SULFATE (200 Mg, Unk) (View Quinine Sulfate Review and Quinine Sulfate Label ).


6940075-9 | Blood Creatine Phosphokinase Increased, Miosis, Narcotic Intoxication, Renal Failure Acute, Somnolence
on Aug 11, 2010 Male patient from UNITED KINGDOM , 79 years of age, was diagnosed with hypercholesterolaemia, polyuria, fluid overload, diabetes mellitus, phantom pain, breakthrough pain, hypertension, left ventricular failure and was treated with Atorvastatin (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, miosis, narcotic intoxication, renal failure acute, somnolence. Atorvastatin dosage: 20 Mg, Qd. During the same period patient was treated with BENDROFLUMETHIAZIDE (2.5 Mg, Qd) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), FUROSEMIDE (40 Mg, Qd) (View Furosemide Review and Furosemide Label ), METFORMIN (500 Mg, Tid) (View Metformin Review and Metformin Label ), OXYCONTIN (40 Mg, Bid) (View Oxycontin Review and Oxycontin Label ), OXYCODONE HCL (10 Mg, Qid) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), RAMIPRIL (7.5 Mg, Qd) (View Ramipril Review and Ramipril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6915011-1 | Mononeuropathy, Rhabdomyolysis
Patient was taking Atorvastatin (View Usage). After Atorvastatin was administered, patient had the following side effects: mononeuropathy, rhabdomyolysis on Jul 26, 2010 from ITALY Additional patient health information: Male patient , 59 years of age, was diagnosed with dyslipidaemia, lung infection, type 2 diabetes mellitus and. Atorvastatin dosage: . During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), INSULIN LISPRO (View Insulin Lispro Review and Insulin Lispro Label ), INSULIN GLARGINE (Total Daily Insulin Dose 48u) (View Insulin Glargine Review and Insulin Glargine Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized and became disabled.

6913706-7 | Arthralgia, Myalgia
Adverse event was reported on Jun 23, 2008 by a Female patient taking Atorvastatin (View Usage) (Dosage: ) was diagnosed with blood cholesterol increased, rheumatoid arthritis (What is rheumatoid arthritis?), hypertension and. Location: UNITED STATES , weighting 135.0 lb, Patient experienced the following unwanted or unexpected effects: arthralgia, myalgia. During the same period patient was treated with HUMIRA (View Humira Review and Humira Label ), DYAZIDE (75/50mg) (View Dyazide Review and Dyazide Label ), RAMIPRIL (2.5 Mg (2.5 Mg, 1 In 1 D)) (View Ramipril Review and Ramipril Label ).

6913578-0 | Rhabdomyolysis
on Aug 05, 2010 Male patient from UNITED STATES , 74 years of age, was diagnosed with hyperlipidaemia and was treated with Atorvastatin (View Usage). Patient had the following side effects: rhabdomyolysis. Atorvastatin dosage: 10 Mg Every Day Po. Patient was hospitalized.

6899900-2 | Blood Creatine Phosphokinase Increased, Miosis, Narcotic Intoxication, Renal Failure Acute, Somnolence
on Jul 20, 2010 Male patient from UNITED KINGDOM , 79 years of age, was diagnosed with hypercholesterolaemia, polyuria, fluid overload, diabetes mellitus, phantom pain, breakthrough pain, hypertension, left ventricular failure and was treated with Atorvastatin (View Usage). After Atorvastatin was administered, patient had the following side effects: blood creatine phosphokinase increased, miosis, narcotic intoxication, renal failure acute, somnolence. Atorvastatin dosage: 20 Mg, Qd. During the same period patient was treated with BENDROFLUMETHIAZIDE (2.5 Mg, Qd) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), FUROSEMIDE (40 Mg, Qd) (View Furosemide Review and Furosemide Label ), METFORMIN HCL (500 Mg, Tid) (View Metformin Hcl Review and Metformin Hcl Label ), OXYCONTIN (40 Mg, Bid) (View Oxycontin Review and Oxycontin Label ), OXYCODONE HCL (10 Mg, Qid) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), RAMIPRIL (7.5 Mg, Qd) (View Ramipril Review and Ramipril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6899632-0 | Mononeuropathy, Rhabdomyolysis
Patient was taking Atorvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: mononeuropathy, rhabdomyolysis on Jul 20, 2010 from ITALY Additional patient health information: Male patient , 59 years of age, was diagnosed with lung infection and. Atorvastatin dosage: 40 Mg, Unk. During the same period patient was treated with CLARITHROMYCIN (500 Mg, Unk) (View Clarithromycin Review and Clarithromycin Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ).

6894165-X | Cardiogenic Shock, Overdose, Renal Failure
Adverse event was reported on Jul 19, 2010 by a Male patient taking Atorvastatin (View Usage) (Dosage: 1200 Mg, Unk) . Location: NETHERLANDS , 75 years of age, Patient had the following side effects: cardiogenic shock, overdose, renal failure. During the same period patient was treated with DIGOXIN (7125 Mg, Unk) (View Digoxin Review and Digoxin Label ), SOTALOL HCL (7200 Mg, Unk) (View Sotalol Hcl Review and Sotalol Hcl Label ), ISOSORBIDE (6000 Mg, Unk) (View Isosorbide Review and Isosorbide Label ), ACENOCOUMAROL (98 Mg, Unk) (View Acenocoumarol Review and Acenocoumarol Label ), PERINDOPRIL (200 Mg, Unk) (View Perindopril Review and Perindopril Label ), FUROSEMIDE (800 Mg, Unk) (View Furosemide Review and Furosemide Label ), AMLODIPINE (300 Mg, Unk) (View Amlodipine Review and Amlodipine Label ).

6826488-4 | Rhabdomyolysis
on Jun 30, 2010 Male patient from UNITED KINGDOM , 74 years of age, was diagnosed with hypercholesterolaemia, osteomyelitis and was treated with Atorvastatin (View Usage). After Atorvastatin was administered, patient had the following side effects: rhabdomyolysis. Atorvastatin dosage: 40 Mg, 1x/day. During the same period patient was treated with FUSIDIC ACID (View Fusidic Acid Review and Fusidic Acid Label ), FLUCLOXACILLIN (500 Mg, 4x/day) (View Flucloxacillin Review and Flucloxacillin Label ), EPOETIN ALFA (6000 Iu, Weekly) (View Epoetin Alfa Review and Epoetin Alfa Label ), ACETYLSALICYLIC ACID (75 Mg, 1x/day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (75 Mg, 1x/day) (View Clopidogrel Review and Clopidogrel Label ), BISOPROLOL FUMARATE (5 Mg, 1x/day) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), SPIRONOLACTONE (25 Mg, 1x/day) (View Spironolactone Review and Spironolactone Label ), AMLODIPINE (5 Mg, 1x/day) (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6819022-6 | Blood Creatine Phosphokinase Increased
on Jun 22, 2010 Male patient from UNITED KINGDOM , 68 years of age, weighting 154.3 lb, was diagnosed with hyperlipidaemia, hypertension and was treated with Atorvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased. Atorvastatin dosage: Daily Dose: 10 Milligram(s). During the same period patient was treated with PERINDOPRIL ERBUMINE (Daily Dose: 2 Milligram(s)) (View Perindopril Erbumine Review and Perindopril Erbumine Label ).

6816693-5 | Hypotension, Stevens-johnson Syndrome
Patient was taking Atorvastatin (View Usage). Patient had the following side effects: hypotension, stevens-johnson syndrome on Jun 22, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 56 years of age, . Atorvastatin dosage: 20 Mg, Unk. During the same period patient was treated with INDAPAMIDE (2.5 Mg, Unk) (View Indapamide Review and Indapamide Label ), PERINDOPRIL (4 Mg, Unk) (View Perindopril Review and Perindopril Label ), RANITIDINE (150 Mg, Bid) (View Ranitidine Review and Ranitidine Label ), ASPIRIN (75 Mg, Unk) (View Aspirin Review and Aspirin Label ), EZETIMIBE (10 Mg, Unk) (View Ezetimibe Review and Ezetimibe Label ), GLUCOSAMINE (100 Mg, Unk) (View Glucosamine Review and Glucosamine Label ), NITROGLYCERIN (2 Df, Unk) (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

6773975-3 | Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mb Increased, Chest Pain, Myalgia
Adverse event was reported on Jun 15, 2010 by a Male patient taking Atorvastatin (View Usage) (Dosage: 80 Mg Every Day Po) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 67 years of age, weighting 204.0 lb, After Atorvastatin was administered, patient had the following side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, chest pain (What is chest pain?), myalgia. During the same period patient was treated with FENOFIBRATE (145 Mg Every Day Po) (View Fenofibrate Review and Fenofibrate Label ). Patient was hospitalized.

6743092-7 | Rhabdomyolysis
on May 12, 2010 Male patient from UNITED KINGDOM , 58 years of age, was diagnosed with wound infection and was treated with Atorvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: rhabdomyolysis. Atorvastatin dosage: 40 Mg, Qd. During the same period patient was treated with CIPROFLOXACIN (500 Mg, Bid) (View Ciprofloxacin Review and Ciprofloxacin Label ), FUCIDINE CAP (500 Mg, Tid) (View Fucidine Cap Review and Fucidine Cap Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ), BISOPROLOL (5 Mg, Qd) (View Bisoprolol Review and Bisoprolol Label ), FRUSEMIDE (20 Mg, Qd) (View Frusemide Review and Frusemide Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized.

6721177-9 | Rectal Haemorrhage
on Apr 28, 2010 Male patient from UNITED KINGDOM , 70 years of age, weighting 224.9 lb, was diagnosed with hypercholesterolaemia and was treated with Atorvastatin (View Usage). Patient had the following side effects: rectal haemorrhage. Atorvastatin dosage: 20 Mg, Unk. During the same period patient was treated with SIMVASTATIN (40 Mg, Unk) (View Simvastatin Review and Simvastatin Label ), ASPIRIN (75 Mg, Unk) (View Aspirin Review and Aspirin Label ), BISOPROLOL (2.5 Mg, Unk) (View Bisoprolol Review and Bisoprolol Label ), CLOPIDOGREL (75 Mg, Unk) (View Clopidogrel Review and Clopidogrel Label ), RAMIPRIL (2.5 Mg, Unk) (View Ramipril Review and Ramipril Label ).

6557303-4 | Hepatitis B, Liver Injury
Patient was taking Atorvastatin (View Usage). After Atorvastatin was administered, patient had the following side effects: hepatitis b (What is hepatitis b?), liver injury on Jan 19, 2010 from JAPAN Additional patient health information: Male patient , 49 years of age, weighting 145.5 lb, was diagnosed with hyperlipidaemia, b-cell lymphoma, infection prophylaxis and. Atorvastatin dosage: 10 Mg, Qd. During the same period patient was treated with PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), FLUCONAZOLE (200 Mg, Qd) (View Fluconazole Review and Fluconazole Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), RITUXIMAB (Unk) (View Rituximab Review and Rituximab Label ), ENTECAVIR (0.5 Mg, Qd) (View Entecavir Review and Entecavir Label ), REBAMIPIDE (300 Mg, Qd) (View Rebamipide Review and Rebamipide Label ).

6532453-7 | Alopecia, Androgenetic Alopecia
Adverse event was reported on Jan 04, 2010 by a Male patient taking Atorvastatin (View Usage) (Dosage: 40 Mg, Qd) was diagnosed with hyperlipidaemia, type 2 diabetes mellitus, hypertension and. Location: UNITED KINGDOM , weighting 179.7 lb, Patient experienced the following unwanted or unexpected effects: alopecia, androgenetic alopecia. During the same period patient was treated with SIMVASTATIN (40 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), AMLODIPINE (5 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), EXENATIDE (10 Ug, Bid) (View Exenatide Review and Exenatide Label ), GLICLAZIDE (80 Mg, Bid) (View Gliclazide Review and Gliclazide Label ), METHYLDOPA (250 Mg, Tid) (View Methyldopa Review and Methyldopa Label ), PIOGLITAZONE (45 Mg, Unk) (View Pioglitazone Review and Pioglitazone Label ).

6470393-2 | Asthenia, Fatigue, Hearing Impaired, Nausea, Visual Impairment
on Nov 30, 2009 Male patient from UNITED KINGDOM , 62 years of age, was diagnosed with hyperlipidaemia and was treated with Atorvastatin (View Usage). Patient had the following side effects: asthenia, fatigue, hearing impaired, nausea (What is nausea?), visual impairment. Atorvastatin dosage: . During the same period patient was treated with BENDROFLUMETHIAZIDE (2.5 Mg, 1x/day) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), BISOPROLOL FUMARATE (10 Mg, 1x/day) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), DEXAMFETAMINE SULFATE (15 Mg, 2x/day) (View Dexamfetamine Sulfate Review and Dexamfetamine Sulfate Label ), FELODIPINE (2.5 Mg, 1x/day) (View Felodipine Review and Felodipine Label ), HYOSCINE BUTYLBROMIDE (10 Mg, 3x/day) (View Hyoscine Butylbromide Review and Hyoscine Butylbromide Label ), LISINOPRIL (20 Mg, 1x/day) (View Lisinopril Review and Lisinopril Label ), OMEPRAZOLE (20 Mg, 1x/day) (View Omeprazole Review and Omeprazole Label ), PARACETAMOL (500 Mg, As Needed) (View Paracetamol Review and Paracetamol Label ).

6458435-1 | Alopecia, Androgenetic Alopecia
on Nov 19, 2009 Male patient from UNITED KINGDOM , weighting 179.7 lb, was diagnosed with hyperlipidaemia, type 2 diabetes mellitus, hypertension and was treated with Atorvastatin (View Usage). After Atorvastatin was administered, patient had the following side effects: alopecia, androgenetic alopecia. Atorvastatin dosage: 40 Mg, Qd. During the same period patient was treated with SIMVASTATIN (40 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), AMLODIPINE (5 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), EXENATIDE (10 Ug, Bid) (View Exenatide Review and Exenatide Label ), GLICLAZIDE (80 Mg, Bid) (View Gliclazide Review and Gliclazide Label ), METHYLDOPA (250 Mg, Tid) (View Methyldopa Review and Methyldopa Label ), PIOGLITAZONE (45 Mg, Unk) (View Pioglitazone Review and Pioglitazone Label ).

6457717-7 | Hepatitis, Jaundice
Patient was taking Atorvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?), jaundice (What is jaundice?) on Nov 19, 2009 from UNITED STATES Additional patient health information: Male patient , 54 years of age, . Atorvastatin dosage: 10 Mg, 1x/day. During the same period patient was treated with METFORMIN (1500 Mg, 1x/day) (View Metformin Review and Metformin Label ). Patient was hospitalized.

6427595-0 | Blood Creatine Phosphokinase Increased, Blood Potassium Increased, Malaise, Metabolic Acidosis, Renal Failure Acute, Rhabdomyolysis, Syncope
Adverse event was reported on Oct 27, 2009 by a Male patient taking Atorvastatin (View Usage) (Dosage: 80 Mg, Unk) was diagnosed with gout (What is gout?) and. Location: UNITED KINGDOM , 66 years of age, Patient had the following side effects: blood creatine phosphokinase increased, blood potassium increased, malaise, metabolic acidosis, renal failure acute, rhabdomyolysis, syncope. During the same period patient was treated with DICLOFENAC (50 Mg, 2x/day Total) (View Diclofenac Review and Diclofenac Label ), EZETIMIBE (10 Mg, Unk) (View Ezetimibe Review and Ezetimibe Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), DIHYDROCODEINE BITARTRATE INJ (View Dihydrocodeine Bitartrate Inj Review and Dihydrocodeine Bitartrate Inj Label ), DOXAZOSIN (View Doxazosin Review and Doxazosin Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ). Patient was hospitalized.

6389323-7 | Hepatitis B, Liver Injury
on Sep 25, 2009 Male patient from JAPAN , 49 years of age, was diagnosed with hyperlipidaemia, b-cell lymphoma, infection prophylaxis and was treated with Atorvastatin (View Usage). After Atorvastatin was administered, patient had the following side effects: hepatitis b (What is hepatitis b?), liver injury. Atorvastatin dosage: 10 Mg, Qd. During the same period patient was treated with PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), CYCLOPHOSPHAMIDE (Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (Unk) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Unk) (View Vincristine Review and Vincristine Label ), RITUXIMAB (Unk) (View Rituximab Review and Rituximab Label ), ENTECAVIR (0.5 Mg, Qd) (View Entecavir Review and Entecavir Label ), REBAMIPIDE (View Rebamipide Review and Rebamipide Label ).

6387546-4 | Hepatitis Cholestatic
on Sep 23, 2009 Female patient from GERMANY , 50 years of age, was diagnosed with hypertension and was treated with Atorvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis cholestatic. Atorvastatin dosage: 20 Mg, Qd. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (20 Mg, Qd) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), FENOFIBRATE (200 Mg, Qd) (View Fenofibrate Review and Fenofibrate Label ), BISOPROLOL (10 Mg, Qd) (View Bisoprolol Review and Bisoprolol Label ), RAMIPRIL (2.5 Mg, Qd) (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6326460-7 | Alopecia, Androgenetic Alopecia
Patient was taking Atorvastatin (View Usage). Patient had the following side effects: alopecia, androgenetic alopecia on Aug 13, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 50 years of age, weighting 179.7 lb, was diagnosed with hyperlipidaemia, type 2 diabetes mellitus, hypertension and. Atorvastatin dosage: 40 Mg, Qd. During the same period patient was treated with SIMVASTATIN (40 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), AMLODIPINE (5 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), EXENATIDE (10 Ug, Bid) (View Exenatide Review and Exenatide Label ), GLICLAZIDE (80 Mg, Bid) (View Gliclazide Review and Gliclazide Label ), METHYLDOPA (250 Mg, Tid) (View Methyldopa Review and Methyldopa Label ), PIOGLITAZONE (45 Mg, Unk) (View Pioglitazone Review and Pioglitazone Label ).

6321533-7 | Amyotrophic Lateral Sclerosis
Adverse event was reported on Aug 14, 2009 by a Male patient taking Atorvastatin (View Usage) (Dosage: ) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 70 years of age, After Atorvastatin was administered, patient had the following side effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?). During the same period patient was treated with EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), CERIVASTATIN (View Cerivastatin Review and Cerivastatin Label ), FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6321531-3 | Amyotrophic Lateral Sclerosis
on Aug 14, 2009 Male patient from UNITED STATES , 71 years of age, was diagnosed with hyperlipidaemia and was treated with Atorvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?). Atorvastatin dosage: 10 Mg, Qd. During the same period patient was treated with SIMVASTATIN (10 Mg, Qod) (View Simvastatin Review and Simvastatin Label ), VYTORIN (View Vytorin Review and Vytorin Label ).

6305808-3 | Amyotrophic Lateral Sclerosis
on Jul 31, 2009 Male patient from UNITED STATES , 71 years of age, was diagnosed with hyperlipidaemia and was treated with Atorvastatin (View Usage). Patient had the following side effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?). Atorvastatin dosage: 10 Mg, Qd. During the same period patient was treated with SIMVASTATIN (10 Mg, Qod) (View Simvastatin Review and Simvastatin Label ), VYTORIN (View Vytorin Review and Vytorin Label ).

6305806-X | Amyotrophic Lateral Sclerosis
Patient was taking Atorvastatin (View Usage). After Atorvastatin was administered, patient had the following side effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?) on Jul 31, 2009 from UNITED STATES Additional patient health information: Male patient , 70 years of age, was diagnosed with hyperlipidaemia and. Atorvastatin dosage: . During the same period patient was treated with EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), CERIVASTATIN (View Cerivastatin Review and Cerivastatin Label ), FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6302244-0 | Alopecia, Androgenetic Alopecia
Adverse event was reported on Jul 29, 2009 by a Female patient taking Atorvastatin (View Usage) (Dosage: 40 Mg, Qd) was diagnosed with hyperlipidaemia, type 2 diabetes mellitus, hypertension and. Location: UNITED KINGDOM , 50 years of age, weighting 179.7 lb, Patient experienced the following unwanted or unexpected effects: alopecia, androgenetic alopecia. During the same period patient was treated with SIMVASTATIN (40 Mg, Qd) (View Simvastatin Review and Simvastatin Label ), AMLODIPINE (5 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), EXENATIDE (10 Ug, Bid) (View Exenatide Review and Exenatide Label ), GLICLAZIDE (80 Mg, Bid) (View Gliclazide Review and Gliclazide Label ), METHYLDOPA (250 Mg, Tid) (View Methyldopa Review and Methyldopa Label ), PIOGLITAZONE (45 Mg, Unk) (View Pioglitazone Review and Pioglitazone Label ).

6300715-4 | Amyotrophic Lateral Sclerosis
on Jul 28, 2009 Male patient from UNITED STATES , 70 years of age, was diagnosed with hyperlipidaemia and was treated with Atorvastatin (View Usage). Patient had the following side effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?). Atorvastatin dosage: . During the same period patient was treated with EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), CERIVASTATIN (View Cerivastatin Review and Cerivastatin Label ), FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6300709-9 | Amyotrophic Lateral Sclerosis
on Jul 28, 2009 Male patient from UNITED STATES , 71 years of age, was diagnosed with hyperlipidaemia and was treated with Atorvastatin (View Usage). After Atorvastatin was administered, patient had the following side effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?). Atorvastatin dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), VYTORIN (View Vytorin Review and Vytorin Label ).

6191649-7 | Asthenia, Hepatitis Toxic, Weight Decreased
Patient was taking Atorvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, hepatitis toxic, weight decreased on May 13, 2009 from SPAIN Additional patient health information: Female patient , 64 years of age, was diagnosed with cerebrovascular accident and. Atorvastatin dosage: 20 Mg, 1x/day. During the same period patient was treated with DIAMICRON (Unk) (View Diamicron Review and Diamicron Label ), ENALAPRIL (Unk) (View Enalapril Review and Enalapril Label ), METFORMIN HCL (850 Mg, 3x/day) (View Metformin Hcl Review and Metformin Hcl Label ), OMEPRAZOLE (20 Unk, 1x/day) (View Omeprazole Review and Omeprazole Label ), SINTROM (View Sintrom Review and Sintrom Label ).

6096952-7 | Blood Creatine Phosphokinase Increased, Myalgia
Adverse event was reported on Feb 25, 2009 by a Male patient taking Atorvastatin (View Usage) (Dosage: 40 Mg Every Day Po) was diagnosed with hyperlipidaemia and. Location: UNITED STATES , 50 years of age, Patient had the following side effects: blood creatine phosphokinase increased, myalgia.

6080847-9 | Cardiac Tamponade
on Feb 11, 2009 Male patient from POLAND , weighting 218.3 lb, was diagnosed with acute coronary syndrome and was treated with Atorvastatin (View Usage). After Atorvastatin was administered, patient had the following side effects: cardiac tamponade. Atorvastatin dosage: . During the same period patient was treated with NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), ABCIXIMAB (View Abciximab Review and Abciximab Label ), CLOPIDOGREL (600 Mg Ld D1 Followed By 150 Mg From D2 To D7; 75 Mg From D8 To 30) (View Clopidogrel Review and Clopidogrel Label ), ASA LOW DOSE (At Least 300 Mg D1; 75-100 Mg From D2 To D30) (View Asa Low Dose Review and Asa Low Dose Label ).

6065779-4 | Abnormal Dreams, Hypersomnia, Listless, Pruritus, Skin Exfoliation
on Jan 28, 2009 Male patient from UNITED KINGDOM , 55 years of age, weighting 208.3 lb, was diagnosed with blood triglycerides increased and was treated with Atorvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal dreams, hypersomnia, listless, pruritus, skin exfoliation. Atorvastatin dosage: 20 Mg, Unk. During the same period patient was treated with SIMVASTATIN (40 Mg, Unk) (View Simvastatin Review and Simvastatin Label ).

6009894-X | Multi-organ Failure, Pancreatitis Acute
Patient was taking Atorvastatin (View Usage). Patient had the following side effects: multi-organ failure, pancreatitis acute on Dec 12, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 56 years of age, weighting 220.5 lb, was diagnosed with hypercholesterolaemia, hypertension, angina pectoris, prophylaxis, diabetes mellitus and. Atorvastatin dosage: 40 Mg, Qd. During the same period patient was treated with BENDROFLUMETHIAZIDE (2.5 Mg, Qd) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), LISINOPRIL (20 Mg, Qd) (View Lisinopril Review and Lisinopril Label ), ADIZEM XL (180 Mg, Qd) (View Adizem-xl Review and Adizem-xl Label ), ADIZEM XL (View Adizem-xl Review and Adizem-xl Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ), NITROGLYCERIN (1 Df, Unk) (View Nitroglycerin Review and Nitroglycerin Label ), METFORMIN HCL (500 Mg, Bid) (View Metformin Hcl Review and Metformin Hcl Label ), NICORANDIL (20 Mg, Unk) (View Nicorandil Review and Nicorandil Label ). Patient was hospitalized.

5971386-1 | Autoimmune Hepatitis, Cholestasis, Fatigue, Hepatic Fibrosis, Jaundice, Liver Injury
Adverse event was reported on Nov 21, 2008 by a Male patient taking Atorvastatin (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia and. Location: UNITED KINGDOM , 55 years of age, After Atorvastatin was administered, patient had the following side effects: autoimmune hepatitis, cholestasis, fatigue, hepatic fibrosis, jaundice (What is jaundice?), liver injury. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), NICORANDIL (View Nicorandil Review and Nicorandil Label ).

5971015-7 | Multi-organ Failure, Pancreatitis Acute
on Nov 18, 2008 Male patient from UNITED KINGDOM , 56 years of age, weighting 220.5 lb, was diagnosed with hypercholesterolaemia, hypertension, angina pectoris, prophylaxis, diabetes mellitus and was treated with Atorvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure, pancreatitis acute. Atorvastatin dosage: 40 Mg, Qd. During the same period patient was treated with BENDROFLUMETHIAZIDE (2.5 Mg, Qd) (View Bendroflumethiazide Review and Bendroflumethiazide Label ), LISINOPRIL (20 Mg, Qd) (View Lisinopril Review and Lisinopril Label ), ADIZEM XL (180 Mg, Qd) (View Adizem-xl Review and Adizem-xl Label ), ADIZEM XL (View Adizem-xl Review and Adizem-xl Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ), NITROGLYCERIN (1 Df, Unk) (View Nitroglycerin Review and Nitroglycerin Label ), METFORMIN HCL (500 Mg, Bid) (View Metformin Hcl Review and Metformin Hcl Label ), NICORANDIL (20 Mg, Unk) (View Nicorandil Review and Nicorandil Label ). Patient was hospitalized.

5970348-8 | Asthenia, Eye Pain, Fatigue, Headache, Hepatitis, Liver Function Test Abnormal, Pyrexia
on Nov 19, 2008 Male patient from UNITED STATES , 55 years of age, weighting 195.3 lb, was diagnosed with sinusitis (What is sinusitis?) and was treated with Atorvastatin (View Usage). Patient had the following side effects: asthenia, eye pain, fatigue, headache (What is headache?), hepatitis (What is hepatitis?), liver function test abnormal, pyrexia. Atorvastatin dosage: Daily Dose:20mg. During the same period patient was treated with TELITHROMYCIN (View Telithromycin Review and Telithromycin Label ).

5967479-5 | Multi-organ Failure, Pancreatitis Acute
Patient was taking Atorvastatin (View Usage). After Atorvastatin was administered, patient had the following side effects: multi-organ failure, pancreatitis acute on Nov 19, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 56 years of age, weighting 220.5 lb, was diagnosed with hypercholesterolaemia, hypertension, angina pectoris, prophylaxis, diabetes mellitus and. Atorvastatin dosage: . During the same period patient was treated with BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ADIZEM XL (View Adizem-xl Review and Adizem-xl Label ), ADIZEM XL (View Adizem-xl Review and Adizem-xl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), NICORANDIL (View Nicorandil Review and Nicorandil Label ). Patient was hospitalized.

5929988-4 | Depression, Suicidal Ideation
Adverse event was reported on Oct 17, 2008 by a Male patient taking Atorvastatin (View Usage) (Dosage: ) was diagnosed with blood cholesterol increased and. Location: UNITED KINGDOM , 49 years of age, Patient experienced the following unwanted or unexpected effects: depression (What is depression?), suicidal ideation. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ).

5913001-9 | Depression, Suicidal Ideation
on Sep 29, 2008 Male patient from UNITED KINGDOM , 49 years of age, was diagnosed with blood cholesterol increased and was treated with Atorvastatin (View Usage). Patient had the following side effects: depression (What is depression?), suicidal ideation. Atorvastatin dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ).

5912992-X | Multi-organ Failure, Pancreatitis Acute
on Oct 02, 2008 Female patient from UNITED KINGDOM , 60 years of age, weighting 185.2 lb, was treated with Atorvastatin (View Usage). After Atorvastatin was administered, patient had the following side effects: multi-organ failure, pancreatitis acute. Atorvastatin dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), ACETAMINOPHEN W/ CODEINE (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), LOPERAMIDE HCL (View Loperamide Hcl Review and Loperamide Hcl Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), VENTOLIN (View Ventolin Review and Ventolin Label ).

5874476-7 | Vasculitis
Patient was taking Atorvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: vasculitis (What is vasculitis?) on Sep 03, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 48 years of age, weighting 224.9 lb, was diagnosed with myocardial ischaemia and. Atorvastatin dosage: . During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ), MINOCYCLINE HYDROCHLORIDE (View Minocycline Hydrochloride Review and Minocycline Hydrochloride Label ), NICORANDIL (View Nicorandil Review and Nicorandil Label ).

5871102-8 | Osteomyelitis, Rhabdomyolysis
Adverse event was reported on Aug 27, 2008 by a Male patient taking Atorvastatin (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia and. Location: UNITED KINGDOM , 74 years of age, Patient had the following side effects: osteomyelitis, rhabdomyolysis. During the same period patient was treated with FUSIDIC ACID (View Fusidic Acid Review and Fusidic Acid Label ), FLOXACILLIN SODIUM (View Floxacillin Sodium Review and Floxacillin Sodium Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5866279-4 | Asthenia, Blood Creatine Phosphokinase Increased, Pain
on Aug 22, 2008 Female patient from UNITED KINGDOM , 82 years of age, weighting 192.5 lb, was diagnosed with myocardial ischaemia, prophylaxis and was treated with Atorvastatin (View Usage). After Atorvastatin was administered, patient had the following side effects: asthenia, blood creatine phosphokinase increased, pain (What is pain?). Atorvastatin dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), BENDROFLUAZIDE (View Bendrofluazide Review and Bendrofluazide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

5858563-5 | Multi-organ Failure, Pancreatitis Acute
on Aug 22, 2008 Male patient from UNITED KINGDOM , 60 years of age, weighting 185.0 lb, was diagnosed with hyperlipidaemia, hypertension and was treated with Atorvastatin (View Usage). Patient experienced the following unwanted or unexpected effects: multi-organ failure, pancreatitis acute. Atorvastatin dosage: . During the same period patient was treated with TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ).

5856844-2 | Arthritis Reactive, Joint Stabilisation, Pain
Patient was taking Atorvastatin (View Usage). Patient had the following side effects: arthritis reactive, joint stabilisation, pain (What is pain?) on Aug 15, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 72 years of age, weighting 198.4 lb, . Atorvastatin dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), METFORMIN (View Metformin Review and Metformin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).